IP Library Granted Patent US 7,141,398
Granted Patent B2
US 7,141,398 · App. 10/745,462 · Granted Nov 28, 2006

Methods for recycling mRNA for linear cRNA amplification

Assignee: Rosetta Inpharmatics LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,141,398
App. No.
10/745,462
Granted
Nov 28, 2006
Kind
B2
Abstract

In one aspect, the present invention provides methods for synthesizing multiple copies of antisense cDNA molecules from an RNA molecule, comprising using an RNA molecule as a template for synthesizing multiple copies of antisense cDNA molecules. In some embodiments of the methods, the RNA molecule is incubated with a primer and with an enzyme possessing reverse transcriptase activity under suitable conditions for synthesizing multiple copies of antisense cDNA molecules. In some embodiments, the methods produce multiple copies of double-stranded cDNA from a template RNA molecule. In further embodiments, the methods produce multiple copies of cRNA from a template RNA molecule.

Claims (29)

1. A method for synthesizing multiple copies of antisense cDNA molecules from an RNA molecule, comprising:

(a) incubating an RNA molecule with a primer and with an enzyme possessing reverse transcriptase activity under suitable conditions for synthesizing a first antisense cDNA molecule to yield a first RNA:DNA hybrid molecule;

(b) denaturing the first RNA:DNA hybrid molecule at a temperature in the range of from 65° C. to 75° C.; and

(c) incubating the RNA molecule with the primer and with the enzyme possessing reverse transcriptase activity under suitable conditions for synthesizing a second antisense cDNA molecule to yield a second RNA:DNA hybrid molecule.

2. The method of claim 1 , wherein the enzyme possessing reverse transcriptase activity lacks RNAse H activity.

3. The method of claim 1 , wherein the enzyme possessing reverse transcriptase activity is heat-stable.

4. The method of claim 1 , wherein the enzyme possessing reverse transcriptase activity is periodically released from a heat-sensitive matrix.

5. The method of claim 1 , wherein the reverse transcriptase activity is stabilized using a stabilizing agent.

6. The method of claim 5 , wherein the stabilizing agent is trehalose.

7. The method of claim 1 , wherein 2 antisense cDNA molecules are synthesized from the RNA molecule.

8. The method of claim 1 , wherein 3 antisense cDNA molecules are synthesized from the RNA molecule.

9. A method for synthesizing multiple copies of double-stranded cDNA molecules from an RNA molecule, comprising:

(a) using an RNA molecule as a template for synthesizing multiple copies of antisense cDNA molecules, wherein the method of synthesis includes incubating an RNA:DNA hybrid molecule at a temperature in the range of from 65° C. to 75° C.; and

(b) using the multiple copies of antisense cDNA molecules as templates for generating double-stranded cDNA molecules.

10. A method for linearly amplifying complementary RNA molecules from an RNA molecule, comprising:

(a) using an RNA molecule as a template for synthesizing multiple copies of antisense cDNA molecules, wherein the method of synthesis includes incubating an RNA:DNA hybrid molecule at a temperature in the range of from 65° C. to 75° C.;

(b) using the multiple copies of antisense cDNA molecules as templates for generating double-stranded cDNA molecules; and

(c) using the double-stranded cDNA molecules as templates for synthesizing complementary RNA.

11. A method for synthesizing multiple copies of double-stranded cDNA molecules from an RNA molecule, comprising:

(a) incubating the RNA molecule with a primer and with a first enzyme possessing reverse transcriptase activity that lacks RNAse H activity under suitable conditions for synthesizing a first RNA:DNA hybrid molecule;

(b) denaturing the first RNA:DNA hybrid molecule at a temperature in the range of from 65° C. to 75° C.;

(c) incubating the RNA molecule with the primer and with the enzyme possessing reverse transcriptase activity under suitable conditions for synthesizing a second antisense cDNA molecule to yield a second RNA:DNA hybrid molecule;

(d) denaturing the second RNA:DNA hybrid molecules at a temperature of 90° C.; and

(e) incubating the antisense cDNA molecules with a primer and a second enzyme possessing DNA polymerase activity under suitable conditions for synthesizing double-stranded cDNA molecules.

12. The method of claim 11 , wherein steps (a) to (c) are repeated at least three times.

13. The method of claim 11 , wherein the reverse transcriptase activity is stabilized using a stabilizing agent.

14. The method of claim 13 , wherein the stabilizing agent is trehalose.

15. The method of claim 11 , wherein the second enzyme possessing DNA polymerase activity also possesses reverse transcriptase activity and RNAse H activity.

16. The method of claim 11 , wherein the second enzyme possessing DNA polymerase activity is MMLV-RT.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2009
From: MERK & CO., INC.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023707/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2009
From: ROSSETTA INPHARMATICS LLC
To: MERCK & CO., INC.
Reel/Frame 023208/0719 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2004
From: ZHOU, MINGJIE; DUENWALD, SVEN; PARRISH, MARK
To: ROSETTA INPHARMATICS LLC
Reel/Frame 014668/0603 →
Continuity (2)
Provisional Application 6043724600 · Dec 30, 2002
Related Publication 20040191814A1 · Sep 30, 2004